The sensitivity of an interferon-γ release assay in microbiologically confirmed pediatric tuberculosis by Schopfer, Kurt et al.
ORIGINAL ARTICLE
The sensitivity of an interferon-γ release assay
in microbiologically confirmed pediatric tuberculosis
Kurt Schopfer & Hans L. Rieder & Thomas Bodmer &
Jacqueline F. Steinlin-Schopfer & Yay Chantana &
Peter Studer & Denis Laurent & Beat Richner
Received: 16 March 2013 /Revised: 11 September 2013 /Accepted: 13 September 2013 /Published online: 25 September 2013
# Springer-Verlag Berlin Heidelberg 2013
Abstract This study aimed at determining the sensitivity of a
whole blood interferon-γ release assay (IGRA) among children
with microbiologically confirmed tuberculosis in a high-burden
country. Children with a diagnosis of tuberculosis based on
clinical and radiographic assessment were tested with an IGRA
in addition to microbiologic examination of appropriate speci-
mens for acid-fast bacilli, mycobacterial rRNA, and observa-
tion for growth of Mycobacterium tuberculosis on appropriate
culture media. Of the 405 children with a clinical diagnosis of
tuberculosis, 91 (22.5 %) had microbiologically confirmed
tuberculosis, of whom 81were tested with an IGRA. A positive
result was obtained in 43 (sensitivity 53.1 %, 95 % confidence
interval 42.3 to 63.6 %), uninfluenced by age, sex, or disease
manifestation. Conclusions : The sensitivity of a whole blood
interferon-γ release assay in microbiologically confirmed pedi-
atric tuberculosis was low. An IGRA cannot, thus, be used as
rule-in test, but it might be useful to rule in tuberculosis among
children in whom tuberculosis is notoriously difficult to con-
firm microbiologically.
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The diagnosis of pediatric tuberculosis proves difficult in any
setting. In high-burden countries with constrained resources,
the diagnosis of childhood tuberculosis is often reliant on
clinical judgment alone. Even with resources available, the
paucibacillary nature of childhood tuberculosis makes its mi-
crobiological confirmation a formidable challenge. Demon-
stration of bacilli by microscopy, culture, or nucleic acid
amplification is feasible in a minority of cases only [4]. The
yield is particularly poor in very young children [15].
We previously reported on the implementation of labora-
tory diagnostic services in a large pediatric referral hospital in
Cambodia [15]. While the focus was on the feasibility of
implementing microbiological services for tuberculosis, an
interferon-γ release assay (IGRA) was also included in the
evaluation of childrenwith a clinical diagnosis of tuberculosis.
The purpose here was to determine the potential contribution
of an IGRA, evaluated against the standard of microbiologi-
cally confirmed tuberculosis.
Material and methods
Setting
The setting has been described [15]. The Jayavarman VII
Hospital in Siem Reap is the largest of the five Kantha Bopha
pediatric referral hospitals in Cambodia. Together, these hos-
pitals took care of about 120,000 hospitalized and 800,000
ambulatory pediatric patients in 2011 [13]. During the period
from 1 July 2005 through 31 March 2006, all children hospi-
talized in this hospital, who are with a clinical diagnosis of
tuberculosis were systematically evaluated based on a proto-
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Procedures and ethics considerations
At admission to the hospital, the child's guardian is requested
to provide informed and signed (fingerprint) consent for the
necessary diagnostic and treatment procedures. This record is
kept as a permanent document in the patient's file. Before
project implementation, diagnosis of tuberculosis was based
on clinical assessment, imaging techniques, and bright field
microscopy. A key purpose of this project was upgrading
diagnostic mycobacteriological techniques on the same spec-
imen with rRNA amplification. The diagnostic procedure was
supplemented by an IGRA in children suspected of having
tuberculosis to establish the presence of tuberculous infection
to enhance the probability to rule in tuberculosis [2].
Methods
Routine laboratory examinations upon admission included
hematology, biochemistry, and urine examinations in accor-
dance with locally established hospital standards. Laboratory
tests, made after obtaining written consent from the child's
guardian, included testing for human immunodeficiency virus
(HIV) with an opt-out approach as recommended [17]. Imag-
ing techniques were utilized at the discretion of the clinician
subsequent to hospital admission once tuberculosis was clin-
ically suspected. Among the children with a clinical diagnosis
of tuberculosis supported by radiographic evidence, routine
laboratory tests were supplemented by a whole blood IGRA
(QuantiFERON®-TB Gold In Tube, Cellestis Ltd., Carnegie,
Australia). The IGRAs were done on the same day as blood
was collected. A positive IGRA result was defined according
to the manufacturer's recommendation.
Tuberculosis-specific laboratory examinations included
collections of clinical specimens: a first one on the spot,
followed by additional ones to preferably obtain three speci-
mens on three consecutive days. All the specimens were
decontaminated and concentrated by centrifugation prior to
splitting into aliquots for microscopy (Ziehl–Neelsen method),
rRNA amplification and culture, respectively, as described [15].
A case of microbiologically confirmed (henceforth, shortened
to “confirmed”) tuberculosis was a patient with at least one
positive result by any of the three methods on at least one
specimen.
Electronic database and analysis
The data were captured in an EpiData relational database
(EpiData Association, version 3.1) and analyzed with EpiData
Analysis version 2.2 (freely available at http://www.epidata.dk)
and OpenEpi (http://www.openepi.com/OE2.3/Menu/
OpenEpiMenu.htm) as appropriate. The data were abstracted
from the paper documents as recorded by health care staff. Up
to three disease sites were electronically captured. Electronic
recoding used an algorithm with a predetermined hierarchy of
intrathoracic (including pulmonary, intrathoracic lymphatic,
and pleural), followed by lymphatic (extrathoracic), soft tissue,
osteoarticular, central nervous system (CNS), and finally other
sites to obtain a uniform classification for major, second, and
third disease sites. We used the classification “intrathoracic”
rather than “pulmonary” because of the difficulties in childhood
tuberculosis of the respiratory tract to clearly separate tubercu-
losis limited to the lung parenchyma (pulmonary) from other
intrathoracic manifestations, primarily the intrathoracic lym-
phatic system. For categorical variables, we determined propor-
tions with 95 % confidence intervals (CI) and odds ratios with
95 % CI for contrasting binomial outcomes. Where deemed
appropriate, adjustments for potentially confounding factors
were made by stratification using the Mantel–Haenszel proce-
dure. For continuous variables, we used standard measures of
central tendency such as means and percentiles.
Results
Four hundred and five children had a clinical diagnosis of
tuberculosis in the period from 1 July 2005 through 31 March
2006. In 91 (22.5 %), the clinical diagnosis was confirmed
(Table 1). Intrathoracic, lymphatic, soft tissue, and osteo-
articular tuberculosis contributed 316 (89.1 %) of all cases,
and 88 (96.7 %) of confirmed cases. The proportion of the
confirmed cases among each of these forms was similar (odds
ratio of the confirmed intrathoracic tuberculosis versus all
other confirmed forms 1.5, 95 % CI 0.9–2.4). Among the 21
cases with tuberculosis of the CNS, only 1 was confirmed and
only 2 of the 23 cases with other disease manifestations.
However, six of an additional seven patients with CNS tuber-
culosis as hierarchically non-primary site had microbiological
confirmation.
While 71 cases (17.5 %) were diagnosed among children
less than 1 year old, only 4 of the 91 confirmed cases were
from this age group. Except for soft tissue tuberculosis, more
boys than girls were diagnosed with tuberculosis, reflecting
the admission pattern [15]. Given a diagnosis of tuberculosis,
confirmation was more often obtained among girls than
among boys (odds ratio 1.64, 95 % CI 1.03–2.6).
Two or more disease sites were noted in 66 patients
(16.3 %). The probability of obtaining confirmation increased
with the number of sites affected (significant chi-square for
trend). Among the children with intrathoracic tuberculosis,
other forms were almost as frequently diagnosed (26 cases)
as major second sites as were lymphatic, soft tissue, osteo-
articular, and CNS tuberculosis combined (29 cases). Of the
405 children, the HIV test result was recorded in 23 (5.7 %)
and was negative in all.
The IGRA results were available for 338 (83.5 %) children:
71 IGRA-positive children, 43 (60.6 %) had confirmed
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tuberculosis. Conversely, 38 (14.2 %) of all children with a
negative IGRA result had confirmed tuberculosis. To further
examine the role of the IGRA, additional analyses were done
among the 338 children with an IGRA result (Table 2). Strat-
ifying by diagnostic type of tuberculosis (clinical diagnosis
versus confirmed diagnosis), 43 of the 81 confirmed cases had
a positive IGRA result (a sensitivity of 53.1 %, 95 % CI 42.3–
63.6 %), as compared to 28 of 257 (10.9 %) children with a
clinical diagnosis but without confirmation. The age-specific
distribution of IGRA positive showed no predilection for any
age group (Fig. 1).
Analyzing the IGRA test results by site of disease, we
found overlapping confidence intervals for the proportion of
a positive IGRA result among patients with intrathoracic
tuberculosis only, intrathoracic plus extrathoracic, and extra-
thoracic tuberculosis only.
The odds ratio of finding a positive IGRA result among the
microbiologically confirmed versus the clinically diagnosed
only cases was 9.2 (Table 3). While the ratio varied somewhat
by age group, sex, and number of disease sites (one versus
two, three or more), these variations were small, and adjust-
ment for all these variables did not make any significant
difference (odds ratio 7.6, 95 % CI 3.7 to 15.7).
Discussion
The diagnosis of tuberculosis in children is fraught with
problems in the operating characteristics, notably test sensi-
tivity, of virtually any assay being used. While systems based
on the identification of molecular methods [12, 15] hold great
promise, the yield remains very low even under optimized
conditions, and complex sample collection procedures are
required (sputum induction and gastric lavage with subse-
quent concentration). The problem is compounded the youn-
ger the children are [15].
Table 2 Univariate analysis of interferon-γ release assay result by case definition (clinical only versus microbiologically confirmed), Jayavarman VII
Hospital, Siem Reap (period of representative sampling is from 1 July 2005 through 31 March 2006)
Characteristic IGRA result Odds ratioa
Clinical cases only Microbiologically confirmed cases Point Confidence interval
Neg Pos % pos Total Neg Pos % pos Total Low High
Total 229 28 10.9 257 38 43 53.1 81 9.3 5.1 16.6
Age group (years)
Under 1 42 2 4.5 44 2 2 50.0 4 21.0 1.9 236.0
1 to <3 44 5 10.2 49 3 8 72.7 11 23.5 4.7 118.3
3 to <5 22 2 8.3 24 4 2 33.3 6 5.5 0.6 51.2
5 and older 121 19 13.6 140 29 31 51.7 60 6.8 6.8 13.7
Sex
Female 92 14 13.2 106 18 24 57.1 42 8.8 3.8 20.1
Male 136 14 9.3 150 20 19 48.7 39 9.2 4.0 21.3
Missing 1 0 0.0 1 0 0 NA 0 NA NA NA
Major site
Intrathoracic 115 12 9.4 127 23 27 54.0 50 11.3 5.0 25.4
Lymphatic 26 2 7.1 28 2 6 75.0 8 39.0 4.5 335.3
Soft tissue 29 3 9.4 32 5 5 50.0 10 9.7 1.7 53.8
Osteoarticular 29 5 14.7 34 6 4 40.0 10 3.9 0.8 18.8
CNS 15 3 16.7 18 0 1 100.0 1 NA NA NA
Other 15 3 16.7 18 2 0 0.0 2 0.0 – –
Number of sites
1 site 209 24 10.3 233 22 27 55.1 49 10.7 5.3 21.6
2 sites 20 4 16.7 24 14 13 48.1 27 4.6 1.3 17.3
3 sites 0 0 NA 0 2 3 60.0 5 NA NA NA
Adjusted odds ratio of a positive IGRA result by case definition, adjusted for age group, sex (one case with missing information excluded), and number
of sites: 7.6 (95 % confidence interval 3.7 to 15.7), suggesting no confounding by the variables considered for adjustment
Neg negative, Pos positive, % pos percentage of positive cases
a Univariate odds of a positive IGRA among microbiological cases divided by odds of a positive IGRA among clinical cases
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The difficulty in obtaining microbiological confirmation of
tuberculosis also affects the choice of the gold standard to
evaluate any new diagnostic technique in childhood tuberculo-
sis. As we have shown [15] even when using different tech-
niques on multiple specimens, tuberculosis could not be con-
firmed in more than three quarters of children with a clinical
diagnosis. This diagnostic shortcoming potentially introduces a
selection bias in test evaluation. Conversely, a large number of
childrenwithmicrobiological confirmationwere available in this
study, providing a fairly sturdy estimate for the test sensitivity.
Thus, a high index of suspicion coupled with clinical
acumen remains the most important prerequisite for the diag-
nosis of tuberculosis in children. The frequency with which
extrathoracic tuberculosis as the sole presentation was
identified in our setting indicates that tuberculosis was high
on the list of the differential diagnosis. It is not surprising that
the frequency of confirmation increased if more than one
disease site was involved because the likelihood of tuberculo-
sis increases with multi-system disease [16]. We were inter-
ested in learning to what extent an IGRA could be of assis-
tance in the diagnosis of tuberculosis in children as demon-
strated in this comparatively large series of 81 confirmed
tuberculosis cases. This issue has been addressed by others
[1, 3, 5, 6, 8, 9, 11]. A limitation to any study of tuberculosis in
children is the gold standard of microbiological confirmation.
It is not surprising that sample sizes in most studies have
commonly been relatively small. Of the above seven studies,
the one from South Africa [9] was the largest (involving 57
cases), the other six included fewer than 30 children. Small
sample sizes result in relatively large reported variations in
IGRA sensitivity, in these studies ranging from 56 to 93 %.
The issue has also been a subject of a meta-analysis [10].
Unfortunately, that analysis mixed “confirmed and/or proba-
ble active” tuberculosis and thus essentially invalidated it.
Among our 81 children with confirmed tuberculosis, only 43
had a positive IGRA, a disappointingly low sensitivity of
53 %. Therefore, an IGRA test result cannot be used as a
rule-out test for tuberculosis and does not substitute microbi-
ological investigation. Conversely, because of the great diffi-
culty in obtaining microbiological confirmation among chil-
dren, a positive result can be useful to rule in tuberculosis.
While only 6 % of our patients had their HIV status recorded,
we have no evidence that there was a selection bias for the
transcription. All 23 of these patients had a negative HIV test
result. This suggests that HIV infection cannot explain the
limited sensitivity of the IGRA in our patient population. The
low frequency of positivity was independent of age, sex, and
multi-system disease. Our study was not designed to deter-
mine IGRA specificity, but specificity is of lesser concern as it
is precisely this characteristic where the test offers a large
advantage over tuberculin skin testing [10]. While research
points to the future possibility to distinguish latent tuberculosis
infection and active disease [7], none of the currently available
immunological tests has that discriminatory ability [14].
In this setting, the sensitivity of the whole blood IGRA for
diagnosing active tuberculosis was (remarkably) low and barely
exceeded 50 % in microbiologically confirmed pediatric tuber-
culosis. This poor sensitivity was not related to age, sex, and
disease manifestation or to HIV infection. Nevertheless, given
the very low yield of microbiological investigations in the very
young child with suspected tuberculosis, the addition of even a
low-sensitivity test may substantially improve the accuracy of
the diagnosis in children under the age of 3 years.
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